Research ArticleCancer Immunotherapy

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer

See allHide authors and affiliations

Sci. Signal.  02 Jan 2018:
Vol. 11, Issue 511, eaan0790
DOI: 10.1126/scisignal.aan0790

Article Information

vol. 11 no. 511

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received March 1, 2017
  • Accepted November 16, 2017

Author Information

  1. Yingjie Nie1,2,
  2. Jiang He3,
  3. Hidekazu Shirota1,
  4. Anna L. Trivett1,
  5. De Yang1,
  6. Dennis M. Klinman1,
  7. Joost J. Oppenheim1,*, and
  8. Xin Chen3,1,*
  1. 1Cancer Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
  2. 2Department of Research, Guizhou Provincial People’s Hospital, Guiyang, Guizhou 550002, China.
  3. 3State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR 999078, China.
  1. *Corresponding author. Email: xchen{at}umac.mo (X.C.); oppenhej{at}mail.nih.gov (J.J.O.)

Altmetric

Article usage

Article usage: December 2017 to July 2018

AbstractFullPdf
Dec 2017753
Jan 201851968991371
Feb 20183063953
Mar 20183163872
Apr 201863845103
May 20183202752
Jun 20181871426
Jul 20181331116